CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, today announced that members of its management team will be presenting at the following upcoming investor conferences in October: Chardan’s 6th Annual Genetic Medicines Conference, New YorkDate: Monday, October 3, 2022Time: 8:30 a.m. ETFormat: Fireside chat 2022
The founder and CEO of ARK Investment Management is buying up drugmaker stocks like they're going out of style.
Warren Buffett famously stated that it's smart to "be fearful when others are greedy and be greedy when others are fearful." All of Wood's ARK Invest exchange-traded funds (ETFs) are down significantly this year. Ginkgo Bioworks specializes in cell programming.